Robert J Gray (Robert Gray, R J Gray)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 20

Top Topics

Combination Therapy

Estrogen Receptor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

JNCI cancer spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Amy S Clark, Fangxin Hong, Richard S Finn, Angela M DeMichele, Edith P Mitchell, James A Zwiebel, Fernanda I Arnaldez, Robert J Gray, Xin Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Mehmet Sitki Copur, Samer S Kasbari, Ravneet Thind, Barbara A Conley, Carlos L Arteaga, Peter J O'Dwyer, Lyndsay N Harris, Helen X Chen, Keith T Flaherty
Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Nathaniel S O'Connell, Fengmin Zhao, Ju-Whei Lee, Edward Haksing Ip, John Devin Peipert, Noah Graham, Mary Lou Smith, Ilana F Gareen, Ruth C Carlos, Samilia Obeng-Gyasi, Joseph A Sparano, Tait D Shanafelt, Mary L Thomas, David Cella, Lynne I Wagner, Robert J Gray
Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Kari B Wisinski, Yael Flamand, Melissa A Wilson, Jason John Luke, Hussein A Tawbi, Fangxin Hong, Edith P Mitchell, James A Zwiebel, Helen Chen, Robert J Gray, Shuli Li, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Robert J Behrens, Kathryn P Pennington, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Trametinib in Patients With NF1- , GNAQ- , or GNA11 -Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2. JCO precision oncology 7 (2023)
Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer, Geoffrey I Shapiro, Lisa Meier McShane, Boris Freidlin, Roisin E O'Cearbhaill, Suzanne George, Julia L Glade Bender, Gary H Lyman, James V Tricoli, David R Patton, Stanley R Hamilton, Robert J Gray, Douglas S Hawkins, Bhanumati Ramineni, Keith T Flaherty, Petros D Grivas, Timothy Anthony Yap, Jordan D Berlin, James H Doroshow, Lyndsay N Harris, Jeffrey A Moscow
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lyndsay N Harris, Charles David Blanke, Harry P Erba, James M Ford, Robert J Gray, Michael L LeBlanc, Siwen Hu-Lieskovan, Mark R Litzow, Selina M Luger, Funda Meric-Bernstam, Peter J O'Dwyer, Megan K D Othus, Katerina Politi, Lois E Shepherd, Carmen J Allegra, Helen X Chen, Susan Percy Ivy, Larissa A Korde, Richard F Little, Lisa Meier McShane, Jeffrey A Moscow, David R Patton, Magdalena Thurin, Laura M Yee, James H Doroshow
The New NCI Precision Medicine Trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer, Geoffrey I Shapiro, Lisa Meier McShane, Boris Freidlin, Roisin E O'Cearbhaill, Suzanne George, Julia L Glade Bender, Gary H Lyman, James V Tricoli, David R Patton, Stanley R Hamilton, Robert J Gray, Douglas S Hawkins, Bhanumati Ramineni, Keith T Flaherty, Petros D Grivas, Timothy Anthony Yap, Jordan D Berlin, James H Doroshow, Lyndsay N Harris, Jeffrey A Moscow
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Aaron S Mansfield, Zihan Wei, R Mehra, A T Shaw, Christopher H Lieu, Patrick M Forde, Alexander E Drilon, E P Mitchell, J J Wright, N Takebe, E Sharon, Daniel H Hovelson, S Tomlins, J Zeng, K Poorman, N Malik, Robert J Gray, S Li, L M McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, S R Hamilton, B A Conley, C L Arteaga, L N Harris, P J O'Dwyer, A P Chen, K T Flaherty
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial. NPJ precision oncology 6 (1) (2022)
Joseph M Unger, Michael LeBlanc, Suzanne George, Norman Wolmark, Walter J Curran, Peter J O'Dwyer, Mitchell D Schnall, Robert S Mannel, Sumithra J Mandrekar, Robert J Gray, Fengmin Zhao, Mariama Bah, Riha Vaidya, Charles D Blanke
Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Philippe L Bedard, Shuli Li, Kari B Wisinski, Eddy Shih-Hsin Yang, Sewanti A Limaye, Edith P Mitchell, James A Zwiebel, Jeffrey A Moscow, Robert J Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-B. JCO precision oncology 6 (2022)
Sherene Loi, Roberto Salgado, Sylvia Adams, Giancarlo Pruneri, Prudence A Francis, Magali Lacroix-Triki, Heikki Joensuu, Maria Vittoria Dieci, Sunil S Badve, Sandra Demaria, Robert J Gray, Elisabetta Munzone, Damien Drubay, Jerome Lemonnier, Christos Sotiriou, Pirkko Liisa Kellokumpu-Lehtinen, Andrea Vingiani, Kathryn Gray, Fabrice Andre, Carsten Denkert, Martine Piccart, Elvire Roblin, Stefan Michiels
Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer. NPJ breast cancer 8 (1) (2022)
Senthil Damodaran, Fengmin Zhao, Dustin A Deming, Edith P Mitchell, John J Wright, Robert J Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jennifer M Suga, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (14) (2022)
Ian E Krop, Opeyemi A Jegede, Juneko E Grilley Olson, Josh D Lauring, Edith P Mitchell, James A Zwiebel, Robert J Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Scott A Kono, James M Ford, Agustin A Garcia, Xingwei D Sui, Robert D Siegel, Brian M Slomovitz, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Taselisib in PIK3CA -Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I. JCO precision oncology 6 (2022)
Sylvia Adams, Megan Othus, Sandip Pravin Patel, Kathy D Miller, Rashmi Chugh, Scott M Schuetze, Mary D Chamberlin, Barbara J Haley, Anna Maria V Storniolo, Mridula P Reddy, Scott A Anderson, Collin T Zimmerman, Anne P O'Dea, Hamid R Mirshahidi, Jordi Rodon Ahnert, Frank J Brescia, Olwen Hahn, Jane M Raymond, David D Biggs, Roisin M Connolly, Elad Sharon, Larissa A Korde, Robert J Gray, Edward Mayerson, Melissa Plets, Charles D Blanke, Young Kwang Chae, Razelle Kurzrock
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609). Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
James M Cleary, Victoria Wang, Rebecca S Heist, E Scott Kopetz, Edith P Mitchell, James A Zwiebel, Kevin S Kapner, Helen X Chen, Shuli Li, Robert J Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, Funda Meric-Bernstam, Melissa S Dillmon, P Mickey Williams, Stanley R Hamilton, Barbara A Conley, Andrew J Aguirre, Peter J O'Dwyer, Lyndsay N Harris, Carlos L Arteaga, Helen X Chen, Keith T Flaherty
Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS-Mutated Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Joseph A Sparano, Michael R Crager, Gong Tang, Robert J Gray, Salomon M Stemmer, Steven Shak
Reply to K. Ando et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (17) (2021)
Douglas B Johnson, Fengmin Zhao, Marcus Noel, Gregory J Riely, Edith P Mitchell, John J Wright, Helen X Chen, Robert J Gray, Shuli Li, Lisa Meier McShane, Lawrence V Rubinstein, David Patton, P Mickey Williams, Stanly R Hamilton, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Keith T Flaherty
Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131). Clinical cancer research : an official journal of the American Association for Cancer Research 26 (8) (2020)
Joseph A Sparano, Michael R Crager, Gong Tang, Robert J Gray, Salomon M Stemmer, Steven Shak
Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (6) (2020)
Ryan J O Dowling, Joseph A Sparano, Pamela J Goodwin, Francois-Clement Bidard, David W Cescon, Sarat Chandarlapaty, Joseph O Deasy, Mitch Dowsett, Robert J Gray, Norah L Henry, Funda Meric-Bernstam, Jane Perlmutter, George W Sledge, Mangesh A Thorat, Scott V Bratman, Lisa Anne Carey, Martin C Chang, Angela DeMichele, Marguerite Ennis, Katarzyna J Jerzak, Larissa A Korde, Ana Elisa Lohmann, Eleftherios P Mamounas, Wendy R Parulekar, Meredith M Regan, Daniel Schramek, Vuk Stambolic, Timothy J Whelan, Antonio C Wolff, James R Woodgett, Kevin Kalinsky, Daniel F Hayes
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions. JNCI cancer spectrum 3 (4) (2019)
Ryan J O Dowling, Kevin Kalinsky, Daniel F Hayes, Francois-Clement Bidard, David W Cescon, Sarat Chandarlapaty, Joseph O Deasy, Mitch Dowsett, Robert J Gray, Norah L Henry, Funda Meric-Bernstam, Jane Perlmutter, George W Sledge, Scott V Bratman, Lisa Anne Carey, Martin C Chang, Angela DeMichele, Marguerite Ennis, Katarzyna J Jerzak, Larissa A Korde, Ana Elisa Lohmann, Eleftherios P Mamounas, Wendy R Parulekar, Meredith M Regan, Daniel Schramek, Vuk Stambolic, Mangesh A Thorat, Timothy J Whelan, Antonio C Wolff, James R Woodgett, Joseph A Sparano, Pamela J Goodwin
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations. JNCI cancer spectrum 3 (4) (2019)
Jinani Jayasekera, Joseph A Sparano, Robert J Gray, Claudine Isaacs, Allison W Kurian, Suzanne O'Neill, Clyde B Schechter, Jeanne S Mandelblatt
Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer. JNCI cancer spectrum 3 (4) (2019)